These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31837525)

  • 1. Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems.
    Indra R; Pompach P; Vavrová K; Jáklová K; Heger Z; Adam V; Eckschlager T; Kopečková K; Arlt VM; Stiborová M
    Environ Toxicol Pharmacol; 2020 Feb; 74():103310. PubMed ID: 31837525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation.
    Indra R; Pompach P; Martínek V; Takácsová P; Vavrová K; Heger Z; Adam V; Eckschlager T; Kopečková K; Arlt VM; Stiborová M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.
    Kolarik M; Indra R; Adam V; Heger Z; Kopeckova K; Arlt VM; Stiborova M
    Neuro Endocrinol Lett; 2019 Feb; 39(7):515-524. PubMed ID: 30860683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s.
    Potega A; Dabrowska E; Niemira M; Kot-Wasik A; Ronseaux S; Henderson CJ; Wolf CR; Mazerska Z
    Drug Metab Dispos; 2011 Aug; 39(8):1423-32. PubMed ID: 21555506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
    Chung WG; Roh HK; Kim HM; Cha YN
    Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans.
    Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
    Kousba A; Soll R; Yee S; Martin M
    Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
    Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
    Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
    Mani C; Hodgson E; Kupfer D
    Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes.
    Rawden HC; Kokwaro GO; Ward SA; Edwards G
    Br J Clin Pharmacol; 2000 Apr; 49(4):313-22. PubMed ID: 10759686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
    Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
    Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450.
    Chung WG; Park CS; Roh HK; Lee WK; Cha YN
    Jpn J Pharmacol; 2000 Oct; 84(2):213-20. PubMed ID: 11128045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of flavin-containing monooxygenase by overproduced nitric oxide in rat liver.
    Park CS; Baek HM; Chung WG; Lee KH; Ryu SD; Cha YN
    Mol Pharmacol; 1999 Sep; 56(3):507-14. PubMed ID: 10462538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion.
    Leoni C; Buratti FM; Testai E
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):343-52. PubMed ID: 18845175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.
    Fedejko-Kap B; Niemira M; Radominska-Pandya A; Mazerska Z
    Xenobiotica; 2011 Dec; 41(12):1044-55. PubMed ID: 21859392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A convenient method to discriminate between cytochrome P450 enzymes and flavin-containing monooxygenases in human liver microsomes.
    Grothusen A; Hardt J; Bräutigam L; Lang D; Böcker R
    Arch Toxicol; 1996; 71(1-2):64-71. PubMed ID: 9010587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
    Usmani KA; Chen WG; Sadeque AJ
    Drug Metab Dispos; 2012 Apr; 40(4):761-71. PubMed ID: 22266842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
    Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
    Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.